Survivor | Non-survivor | Chi-square value | P | |
---|---|---|---|---|
Gender (male/female) | 15/6 | 5/3 | 0.216 | 0.68 |
Underlying disease: malignant/nonmalignant | 3/5 | 12/9 | 0.895 | 0.43 |
Preconditioning: myeloablative/nonmyeloablative | 4/4 | 14/5 | 2.032 | 0.34 |
Donor (related/unrelated) | 1/7 | 10/11 | 3.035 | 0.11 |
aGVHD (Y/N) | 3/5 | 9/12 | 0.069 | 1.0 |
MV (Y/N) | 3/5 | 17/4 | 5.11 | 0.04 |
Renal replacement (Y/N) | 1/7 | 3/18 | 0.016 | 1.0 |
Vasoactive agent (Y/N) | 1/7 | 12/9 | 4.668 | 0.04 |